Cargando…

Reactivation of M. tuberculosis Infection in Trans-Membrane Tumour Necrosis Factor Mice

Of those individuals who are infected with M. tuberculosis, 90% do not develop active disease and represents a large reservoir of M. tuberculosis with the potential for reactivation of infection. Sustained TNF expression is required for containment of persistent infection and TNF neutralization lead...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dambuza, Ivy, Keeton, Roanne, Allie, Nasiema, Hsu, Nai-Jen, Randall, Philippa, Sebesho, Boipelo, Fick, Lizette, Quesniaux, Valerie J. F., Jacobs, Muazzam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221652/ https://www.ncbi.nlm.nih.gov/pubmed/22132068 http://dx.doi.org/10.1371/journal.pone.0025121

Ejemplares similares

TNF-dependent regulation and activation of innate immune cells are essential for host protection against cerebral tuberculosis
por: Francisco, Ngiambudulu M., et al.
Publicado: (2015)

Persistent p55TNFR expression impairs T cell responses during chronic tuberculosis and promotes reactivation
por: Dambuza, Ivy M., et al.
Publicado: (2016)

Complete ablation of tumor necrosis factor decreases the production of IgA, IgG, and IgM in experimental central nervous system tuberculosis
por: Francisco, Ngiambudulu M., et al.
Publicado: (2020)

Protective role of membrane tumour necrosis factor in the host’s resistance to mycobacterial infection
por: Allie, Nasiema, et al.
Publicado: (2008)

Myeloid and T Cell-Derived TNF Protects against Central Nervous System Tuberculosis
por: Hsu, Nai-Jen, et al.
Publicado: (2017)

Prominent role for T cell-derived Tumour Necrosis Factor for sustained control of Mycobacterium tuberculosis infection
por: Allie, Nasiema, et al.
Publicado: (2013)

Membrane TNF confers protection to acute mycobacterial infection
por: Fremond, Cecile, et al.
Publicado: (2005)

Immunity Against Bacterial Infection of the Central Nervous System: An Astrocyte Perspective
por: Geyer, Sohair, et al.
Publicado: (2019)

Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour
por: Micallef, Sarah, et al.
Publicado: (2020)

Microglia are crucial regulators of neuro-immunity during central nervous system tuberculosis
por: Spanos, Jonathan Paul, et al.
Publicado: (2015)

C-type lectins in immunity: recent developments
por: Dambuza, Ivy M, et al.
Publicado: (2015)

Unmasking a fungal fire
por: Dambuza, Ivy M., et al.
Publicado: (2023)

Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection
por: Belmellat, Nadia, et al.
Publicado: (2017)

The Relationship of Fever to Tumour Necrosis in the Rat
por: Allen, Ingrid V.
Publicado: (1964)

IL-4 Receptor-Alpha Signalling of Intestinal Epithelial Cells, Smooth Muscle Cells, and Macrophages Plays a Redundant Role in Oxazolone Colitis
por: Hoving, Jennifer Claire, et al.
Publicado: (2020)

Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
por: Dernfalk, J, et al.
Publicado: (2004)

Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG
por: Bourigault, Marie-Laure, et al.
Publicado: (2013)

GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection
por: Benmerzoug, Sulayman, et al.
Publicado: (2018)

T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors
por: Speakman, Emily A., et al.
Publicado: (2020)

Carnitine and congeners as regulators of tumour necrosis factor
por: De Simone, Claudio, et al.
Publicado: (1993)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?
por: Wigmore, S J, et al.
Publicado: (2003)

Tumour necrosis factor signalling in health and disease
por: Holbrook, Jonathan, et al.
Publicado: (2019)

Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.
por: MÃ¤nnel, D. N., et al.
Publicado: (1989)

Trans-Urethral Diathermy in the Diagnosis and Treatment of Tumours of the Bladder
por: Galbraith, Walter W.
Publicado: (1929)

IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis
por: Gasse, Paméla, et al.
Publicado: (2011)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy
por: Chavez-Galan, Leslie, et al.
Publicado: (2017)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

Draft Whole-Genome Sequence and Annotation of Xenorhabdus griffiniae Strain BMMCB Associated with the South African Entomopathogenic Nematode Steinernema khoisanae Strain BMMCB
por: Mothupi, Boipelo, et al.
Publicado: (2015)

Tumour necrosis factor in man: clinical and biological observations.
por: Selby, P., et al.
Publicado: (1987)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction
por: Vasilev, Sasa, et al.
Publicado: (2015)

Immunological and prognostic significance of tumour necrosis in colorectal cancer
por: Kastinen, Meeri, et al.
Publicado: (2023)

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Editorial: Immunological Memory to Fungal Infections and Vaccine Development
por: Nicola, André Moraes, et al.
Publicado: (2022)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_q3p3k50gbt5ll2uli8ncjioo3s